▶ 調査レポート

ヌクレオチド二ナトリウム(I + G)のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Disodium Nucleotide (I+G) Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。ヌクレオチド二ナトリウム(I + G)のグローバル市場インサイト・予測(~2028年) / Global Disodium Nucleotide (I+G) Market Insights, Forecast to 2028 / QY2207C1119資料のイメージです。• レポートコード:QY2207C1119
• 出版社/出版日:QYResearch / 2022年7月8日
• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のヌクレオチド二ナトリウム(I + G)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヌクレオチド二ナトリウム(I + G)の世界市場のxxx%を占める「医薬品用」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「食品」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のヌクレオチド二ナトリウム(I + G)の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのヌクレオチド二ナトリウム(I + G)市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのヌクレオチド二ナトリウム(I + G)市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

ヌクレオチド二ナトリウム(I + G)のグローバル主要メーカーには、CJ、Ajinomoto Co., Inc.、MeiHua Holdings Group、Star Lake Bioscience Co., Inc.、Fooding Group Limitedなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ヌクレオチド二ナトリウム(I + G)市場は、種類と用途によって区分されます。世界のヌクレオチド二ナトリウム(I + G)市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
医薬品用、食品用

【用途別セグメント】
食品、医薬品、工業、生化学、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ヌクレオチド二ナトリウム(I + G)製品概要
- 種類別市場(医薬品用、食品用)
- 用途別市場(食品、医薬品、工業、生化学、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のヌクレオチド二ナトリウム(I + G)販売量予測2017-2028
- 世界のヌクレオチド二ナトリウム(I + G)売上予測2017-2028
- ヌクレオチド二ナトリウム(I + G)の地域別販売量
- ヌクレオチド二ナトリウム(I + G)の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ヌクレオチド二ナトリウム(I + G)販売量
- 主要メーカー別ヌクレオチド二ナトリウム(I + G)売上
- 主要メーカー別ヌクレオチド二ナトリウム(I + G)価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(医薬品用、食品用)
- ヌクレオチド二ナトリウム(I + G)の種類別販売量
- ヌクレオチド二ナトリウム(I + G)の種類別売上
- ヌクレオチド二ナトリウム(I + G)の種類別価格
・用途別市場規模(食品、医薬品、工業、生化学、その他)
- ヌクレオチド二ナトリウム(I + G)の用途別販売量
- ヌクレオチド二ナトリウム(I + G)の用途別売上
- ヌクレオチド二ナトリウム(I + G)の用途別価格
・北米市場
- 北米のヌクレオチド二ナトリウム(I + G)市場規模(種類別、用途別)
- 主要国別のヌクレオチド二ナトリウム(I + G)市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのヌクレオチド二ナトリウム(I + G)市場規模(種類別、用途別)
- 主要国別のヌクレオチド二ナトリウム(I + G)市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のヌクレオチド二ナトリウム(I + G)市場規模(種類別、用途別)
- 主要国別のヌクレオチド二ナトリウム(I + G)市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のヌクレオチド二ナトリウム(I + G)市場規模(種類別、用途別)
- 主要国別のヌクレオチド二ナトリウム(I + G)市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのヌクレオチド二ナトリウム(I + G)市場規模(種類別、用途別)
- 主要国別のヌクレオチド二ナトリウム(I + G)市場規模(トルコ、サウジアラビア)
・企業情報
CJ、Ajinomoto Co., Inc.、MeiHua Holdings Group、Star Lake Bioscience Co., Inc.、Fooding Group Limited
・産業チェーン及び販売チャネル分析
- ヌクレオチド二ナトリウム(I + G)の産業チェーン分析
- ヌクレオチド二ナトリウム(I + G)の原材料
- ヌクレオチド二ナトリウム(I + G)の生産プロセス
- ヌクレオチド二ナトリウム(I + G)の販売及びマーケティング
- ヌクレオチド二ナトリウム(I + G)の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ヌクレオチド二ナトリウム(I + G)の産業動向
- ヌクレオチド二ナトリウム(I + G)のマーケットドライバー
- ヌクレオチド二ナトリウム(I + G)の課題
- ヌクレオチド二ナトリウム(I + G)の阻害要因
・主な調査結果

Market Analysis and Insights: Global Disodium Nucleotide (I+G) Market
Due to the COVID-19 pandemic, the global Disodium Nucleotide (I+G) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Pharmaceutical Grade accounting for % of the Disodium Nucleotide (I+G) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Food segment is altered to an % CAGR throughout this forecast period.
China Disodium Nucleotide (I+G) market size is valued at US$ million in 2021, while the US and Europe Disodium Nucleotide (I+G) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Disodium Nucleotide (I+G) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Disodium Nucleotide (I+G) include CJ, Ajinomoto Co., Inc., MeiHua Holdings Group, Star Lake Bioscience Co., Inc. and Fooding Group Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Disodium Nucleotide (I+G) capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Disodium Nucleotide (I+G) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Disodium Nucleotide (I+G) Scope and Segment
Disodium Nucleotide (I+G) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Disodium Nucleotide (I+G) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Pharmaceutical Grade
Food Grade
Segment by Application
Food
Pharmaceutical
Industry
Daily Chemical
Others
By Company
CJ
Ajinomoto Co., Inc.
MeiHua Holdings Group
Star Lake Bioscience Co., Inc.
Fooding Group Limited
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Disodium Nucleotide (I+G) Product Introduction
1.2 Market by Type
1.2.1 Global Disodium Nucleotide (I+G) Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Pharmaceutical Grade
1.2.3 Food Grade
1.3 Market by Application
1.3.1 Global Disodium Nucleotide (I+G) Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Food
1.3.3 Pharmaceutical
1.3.4 Industry
1.3.5 Daily Chemical
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Disodium Nucleotide (I+G) Production
2.1 Global Disodium Nucleotide (I+G) Production Capacity (2017-2028)
2.2 Global Disodium Nucleotide (I+G) Production by Region: 2017 VS 2021 VS 2028
2.3 Global Disodium Nucleotide (I+G) Production by Region
2.3.1 Global Disodium Nucleotide (I+G) Historic Production by Region (2017-2022)
2.3.2 Global Disodium Nucleotide (I+G) Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Disodium Nucleotide (I+G) Sales in Volume & Value Estimates and Forecasts
3.1 Global Disodium Nucleotide (I+G) Sales Estimates and Forecasts 2017-2028
3.2 Global Disodium Nucleotide (I+G) Revenue Estimates and Forecasts 2017-2028
3.3 Global Disodium Nucleotide (I+G) Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Disodium Nucleotide (I+G) Sales by Region
3.4.1 Global Disodium Nucleotide (I+G) Sales by Region (2017-2022)
3.4.2 Global Sales Disodium Nucleotide (I+G) by Region (2023-2028)
3.5 Global Disodium Nucleotide (I+G) Revenue by Region
3.5.1 Global Disodium Nucleotide (I+G) Revenue by Region (2017-2022)
3.5.2 Global Disodium Nucleotide (I+G) Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Disodium Nucleotide (I+G) Production Capacity by Manufacturers
4.2 Global Disodium Nucleotide (I+G) Sales by Manufacturers
4.2.1 Global Disodium Nucleotide (I+G) Sales by Manufacturers (2017-2022)
4.2.2 Global Disodium Nucleotide (I+G) Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Disodium Nucleotide (I+G) in 2021
4.3 Global Disodium Nucleotide (I+G) Revenue by Manufacturers
4.3.1 Global Disodium Nucleotide (I+G) Revenue by Manufacturers (2017-2022)
4.3.2 Global Disodium Nucleotide (I+G) Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Disodium Nucleotide (I+G) Revenue in 2021
4.4 Global Disodium Nucleotide (I+G) Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Disodium Nucleotide (I+G) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Disodium Nucleotide (I+G) Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Disodium Nucleotide (I+G) Sales by Type
5.1.1 Global Disodium Nucleotide (I+G) Historical Sales by Type (2017-2022)
5.1.2 Global Disodium Nucleotide (I+G) Forecasted Sales by Type (2023-2028)
5.1.3 Global Disodium Nucleotide (I+G) Sales Market Share by Type (2017-2028)
5.2 Global Disodium Nucleotide (I+G) Revenue by Type
5.2.1 Global Disodium Nucleotide (I+G) Historical Revenue by Type (2017-2022)
5.2.2 Global Disodium Nucleotide (I+G) Forecasted Revenue by Type (2023-2028)
5.2.3 Global Disodium Nucleotide (I+G) Revenue Market Share by Type (2017-2028)
5.3 Global Disodium Nucleotide (I+G) Price by Type
5.3.1 Global Disodium Nucleotide (I+G) Price by Type (2017-2022)
5.3.2 Global Disodium Nucleotide (I+G) Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Disodium Nucleotide (I+G) Sales by Application
6.1.1 Global Disodium Nucleotide (I+G) Historical Sales by Application (2017-2022)
6.1.2 Global Disodium Nucleotide (I+G) Forecasted Sales by Application (2023-2028)
6.1.3 Global Disodium Nucleotide (I+G) Sales Market Share by Application (2017-2028)
6.2 Global Disodium Nucleotide (I+G) Revenue by Application
6.2.1 Global Disodium Nucleotide (I+G) Historical Revenue by Application (2017-2022)
6.2.2 Global Disodium Nucleotide (I+G) Forecasted Revenue by Application (2023-2028)
6.2.3 Global Disodium Nucleotide (I+G) Revenue Market Share by Application (2017-2028)
6.3 Global Disodium Nucleotide (I+G) Price by Application
6.3.1 Global Disodium Nucleotide (I+G) Price by Application (2017-2022)
6.3.2 Global Disodium Nucleotide (I+G) Price Forecast by Application (2023-2028)
7 North America
7.1 North America Disodium Nucleotide (I+G) Market Size by Type
7.1.1 North America Disodium Nucleotide (I+G) Sales by Type (2017-2028)
7.1.2 North America Disodium Nucleotide (I+G) Revenue by Type (2017-2028)
7.2 North America Disodium Nucleotide (I+G) Market Size by Application
7.2.1 North America Disodium Nucleotide (I+G) Sales by Application (2017-2028)
7.2.2 North America Disodium Nucleotide (I+G) Revenue by Application (2017-2028)
7.3 North America Disodium Nucleotide (I+G) Sales by Country
7.3.1 North America Disodium Nucleotide (I+G) Sales by Country (2017-2028)
7.3.2 North America Disodium Nucleotide (I+G) Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Disodium Nucleotide (I+G) Market Size by Type
8.1.1 Europe Disodium Nucleotide (I+G) Sales by Type (2017-2028)
8.1.2 Europe Disodium Nucleotide (I+G) Revenue by Type (2017-2028)
8.2 Europe Disodium Nucleotide (I+G) Market Size by Application
8.2.1 Europe Disodium Nucleotide (I+G) Sales by Application (2017-2028)
8.2.2 Europe Disodium Nucleotide (I+G) Revenue by Application (2017-2028)
8.3 Europe Disodium Nucleotide (I+G) Sales by Country
8.3.1 Europe Disodium Nucleotide (I+G) Sales by Country (2017-2028)
8.3.2 Europe Disodium Nucleotide (I+G) Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Disodium Nucleotide (I+G) Market Size by Type
9.1.1 Asia Pacific Disodium Nucleotide (I+G) Sales by Type (2017-2028)
9.1.2 Asia Pacific Disodium Nucleotide (I+G) Revenue by Type (2017-2028)
9.2 Asia Pacific Disodium Nucleotide (I+G) Market Size by Application
9.2.1 Asia Pacific Disodium Nucleotide (I+G) Sales by Application (2017-2028)
9.2.2 Asia Pacific Disodium Nucleotide (I+G) Revenue by Application (2017-2028)
9.3 Asia Pacific Disodium Nucleotide (I+G) Sales by Region
9.3.1 Asia Pacific Disodium Nucleotide (I+G) Sales by Region (2017-2028)
9.3.2 Asia Pacific Disodium Nucleotide (I+G) Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Disodium Nucleotide (I+G) Market Size by Type
10.1.1 Latin America Disodium Nucleotide (I+G) Sales by Type (2017-2028)
10.1.2 Latin America Disodium Nucleotide (I+G) Revenue by Type (2017-2028)
10.2 Latin America Disodium Nucleotide (I+G) Market Size by Application
10.2.1 Latin America Disodium Nucleotide (I+G) Sales by Application (2017-2028)
10.2.2 Latin America Disodium Nucleotide (I+G) Revenue by Application (2017-2028)
10.3 Latin America Disodium Nucleotide (I+G) Sales by Country
10.3.1 Latin America Disodium Nucleotide (I+G) Sales by Country (2017-2028)
10.3.2 Latin America Disodium Nucleotide (I+G) Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Disodium Nucleotide (I+G) Market Size by Type
11.1.1 Middle East and Africa Disodium Nucleotide (I+G) Sales by Type (2017-2028)
11.1.2 Middle East and Africa Disodium Nucleotide (I+G) Revenue by Type (2017-2028)
11.2 Middle East and Africa Disodium Nucleotide (I+G) Market Size by Application
11.2.1 Middle East and Africa Disodium Nucleotide (I+G) Sales by Application (2017-2028)
11.2.2 Middle East and Africa Disodium Nucleotide (I+G) Revenue by Application (2017-2028)
11.3 Middle East and Africa Disodium Nucleotide (I+G) Sales by Country
11.3.1 Middle East and Africa Disodium Nucleotide (I+G) Sales by Country (2017-2028)
11.3.2 Middle East and Africa Disodium Nucleotide (I+G) Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 CJ
12.1.1 CJ Corporation Information
12.1.2 CJ Overview
12.1.3 CJ Disodium Nucleotide (I+G) Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 CJ Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 CJ Recent Developments
12.2 Ajinomoto Co., Inc.
12.2.1 Ajinomoto Co., Inc. Corporation Information
12.2.2 Ajinomoto Co., Inc. Overview
12.2.3 Ajinomoto Co., Inc. Disodium Nucleotide (I+G) Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Ajinomoto Co., Inc. Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Ajinomoto Co., Inc. Recent Developments
12.3 MeiHua Holdings Group
12.3.1 MeiHua Holdings Group Corporation Information
12.3.2 MeiHua Holdings Group Overview
12.3.3 MeiHua Holdings Group Disodium Nucleotide (I+G) Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 MeiHua Holdings Group Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 MeiHua Holdings Group Recent Developments
12.4 Star Lake Bioscience Co., Inc.
12.4.1 Star Lake Bioscience Co., Inc. Corporation Information
12.4.2 Star Lake Bioscience Co., Inc. Overview
12.4.3 Star Lake Bioscience Co., Inc. Disodium Nucleotide (I+G) Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Star Lake Bioscience Co., Inc. Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Star Lake Bioscience Co., Inc. Recent Developments
12.5 Fooding Group Limited
12.5.1 Fooding Group Limited Corporation Information
12.5.2 Fooding Group Limited Overview
12.5.3 Fooding Group Limited Disodium Nucleotide (I+G) Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Fooding Group Limited Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Fooding Group Limited Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Disodium Nucleotide (I+G) Industry Chain Analysis
13.2 Disodium Nucleotide (I+G) Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Disodium Nucleotide (I+G) Production Mode & Process
13.4 Disodium Nucleotide (I+G) Sales and Marketing
13.4.1 Disodium Nucleotide (I+G) Sales Channels
13.4.2 Disodium Nucleotide (I+G) Distributors
13.5 Disodium Nucleotide (I+G) Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Disodium Nucleotide (I+G) Industry Trends
14.2 Disodium Nucleotide (I+G) Market Drivers
14.3 Disodium Nucleotide (I+G) Market Challenges
14.4 Disodium Nucleotide (I+G) Market Restraints
15 Key Finding in The Global Disodium Nucleotide (I+G) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Disodium Nucleotide (I+G) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Pharmaceutical Grade
Table 3. Major Manufacturers of Food Grade
Table 4. Global Disodium Nucleotide (I+G) Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Disodium Nucleotide (I+G) Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Disodium Nucleotide (I+G) Production by Region (2017-2022) & (Tons)
Table 7. Global Disodium Nucleotide (I+G) Production Market Share by Region (2017-2022)
Table 8. Global Disodium Nucleotide (I+G) Production by Region (2023-2028) & (Tons)
Table 9. Global Disodium Nucleotide (I+G) Production Market Share by Region (2023-2028)
Table 10. Global Disodium Nucleotide (I+G) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Disodium Nucleotide (I+G) Sales by Region (2017-2022) & (Tons)
Table 12. Global Disodium Nucleotide (I+G) Sales Market Share by Region (2017-2022)
Table 13. Global Disodium Nucleotide (I+G) Sales by Region (2023-2028) & (Tons)
Table 14. Global Disodium Nucleotide (I+G) Sales Market Share by Region (2023-2028)
Table 15. Global Disodium Nucleotide (I+G) Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Disodium Nucleotide (I+G) Revenue Market Share by Region (2017-2022)
Table 17. Global Disodium Nucleotide (I+G) Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Disodium Nucleotide (I+G) Revenue Market Share by Region (2023-2028)
Table 19. Global Disodium Nucleotide (I+G) Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Disodium Nucleotide (I+G) Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Disodium Nucleotide (I+G) Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Disodium Nucleotide (I+G) Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Disodium Nucleotide (I+G) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Disodium Nucleotide (I+G) Revenue Share by Manufacturers (2017-2022)
Table 25. Disodium Nucleotide (I+G) Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Disodium Nucleotide (I+G) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Disodium Nucleotide (I+G) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disodium Nucleotide (I+G) as of 2021)
Table 28. Disodium Nucleotide (I+G) Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Disodium Nucleotide (I+G) Product Offered
Table 30. Date of Manufacturers Enter into Disodium Nucleotide (I+G) Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Disodium Nucleotide (I+G) Sales by Type (2017-2022) & (Tons)
Table 33. Global Disodium Nucleotide (I+G) Sales by Type (2023-2028) & (Tons)
Table 34. Global Disodium Nucleotide (I+G) Sales Share by Type (2017-2022)
Table 35. Global Disodium Nucleotide (I+G) Sales Share by Type (2023-2028)
Table 36. Global Disodium Nucleotide (I+G) Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Disodium Nucleotide (I+G) Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Disodium Nucleotide (I+G) Revenue Share by Type (2017-2022)
Table 39. Global Disodium Nucleotide (I+G) Revenue Share by Type (2023-2028)
Table 40. Disodium Nucleotide (I+G) Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Disodium Nucleotide (I+G) Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Disodium Nucleotide (I+G) Sales by Application (2017-2022) & (Tons)
Table 43. Global Disodium Nucleotide (I+G) Sales by Application (2023-2028) & (Tons)
Table 44. Global Disodium Nucleotide (I+G) Sales Share by Application (2017-2022)
Table 45. Global Disodium Nucleotide (I+G) Sales Share by Application (2023-2028)
Table 46. Global Disodium Nucleotide (I+G) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Disodium Nucleotide (I+G) Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Disodium Nucleotide (I+G) Revenue Share by Application (2017-2022)
Table 49. Global Disodium Nucleotide (I+G) Revenue Share by Application (2023-2028)
Table 50. Disodium Nucleotide (I+G) Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Disodium Nucleotide (I+G) Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Disodium Nucleotide (I+G) Sales by Type (2017-2022) & (Tons)
Table 53. North America Disodium Nucleotide (I+G) Sales by Type (2023-2028) & (Tons)
Table 54. North America Disodium Nucleotide (I+G) Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Disodium Nucleotide (I+G) Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Disodium Nucleotide (I+G) Sales by Application (2017-2022) & (Tons)
Table 57. North America Disodium Nucleotide (I+G) Sales by Application (2023-2028) & (Tons)
Table 58. North America Disodium Nucleotide (I+G) Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Disodium Nucleotide (I+G) Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Disodium Nucleotide (I+G) Sales by Country (2017-2022) & (Tons)
Table 61. North America Disodium Nucleotide (I+G) Sales by Country (2023-2028) & (Tons)
Table 62. North America Disodium Nucleotide (I+G) Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Disodium Nucleotide (I+G) Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Disodium Nucleotide (I+G) Sales by Type (2017-2022) & (Tons)
Table 65. Europe Disodium Nucleotide (I+G) Sales by Type (2023-2028) & (Tons)
Table 66. Europe Disodium Nucleotide (I+G) Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Disodium Nucleotide (I+G) Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Disodium Nucleotide (I+G) Sales by Application (2017-2022) & (Tons)
Table 69. Europe Disodium Nucleotide (I+G) Sales by Application (2023-2028) & (Tons)
Table 70. Europe Disodium Nucleotide (I+G) Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Disodium Nucleotide (I+G) Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Disodium Nucleotide (I+G) Sales by Country (2017-2022) & (Tons)
Table 73. Europe Disodium Nucleotide (I+G) Sales by Country (2023-2028) & (Tons)
Table 74. Europe Disodium Nucleotide (I+G) Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Disodium Nucleotide (I+G) Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Disodium Nucleotide (I+G) Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Disodium Nucleotide (I+G) Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Disodium Nucleotide (I+G) Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Disodium Nucleotide (I+G) Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Disodium Nucleotide (I+G) Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Disodium Nucleotide (I+G) Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Disodium Nucleotide (I+G) Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Disodium Nucleotide (I+G) Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Disodium Nucleotide (I+G) Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Disodium Nucleotide (I+G) Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Disodium Nucleotide (I+G) Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Disodium Nucleotide (I+G) Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Disodium Nucleotide (I+G) Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Disodium Nucleotide (I+G) Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Disodium Nucleotide (I+G) Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Disodium Nucleotide (I+G) Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Disodium Nucleotide (I+G) Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Disodium Nucleotide (I+G) Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Disodium Nucleotide (I+G) Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Disodium Nucleotide (I+G) Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Disodium Nucleotide (I+G) Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Disodium Nucleotide (I+G) Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Disodium Nucleotide (I+G) Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Disodium Nucleotide (I+G) Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Disodium Nucleotide (I+G) Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Disodium Nucleotide (I+G) Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Disodium Nucleotide (I+G) Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Disodium Nucleotide (I+G) Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Disodium Nucleotide (I+G) Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Disodium Nucleotide (I+G) Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Disodium Nucleotide (I+G) Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Disodium Nucleotide (I+G) Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Disodium Nucleotide (I+G) Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Disodium Nucleotide (I+G) Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Disodium Nucleotide (I+G) Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Disodium Nucleotide (I+G) Revenue by Country (2023-2028) & (US$ Million)
Table 112. CJ Corporation Information
Table 113. CJ Description and Major Businesses
Table 114. CJ Disodium Nucleotide (I+G) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. CJ Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CJ Recent Development
Table 117. Ajinomoto Co., Inc. Corporation Information
Table 118. Ajinomoto Co., Inc. Description and Major Businesses
Table 119. Ajinomoto Co., Inc. Disodium Nucleotide (I+G) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Ajinomoto Co., Inc. Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Ajinomoto Co., Inc. Recent Development
Table 122. MeiHua Holdings Group Corporation Information
Table 123. MeiHua Holdings Group Description and Major Businesses
Table 124. MeiHua Holdings Group Disodium Nucleotide (I+G) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. MeiHua Holdings Group Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. MeiHua Holdings Group Recent Development
Table 127. Star Lake Bioscience Co., Inc. Corporation Information
Table 128. Star Lake Bioscience Co., Inc. Description and Major Businesses
Table 129. Star Lake Bioscience Co., Inc. Disodium Nucleotide (I+G) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Star Lake Bioscience Co., Inc. Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Star Lake Bioscience Co., Inc. Recent Development
Table 132. Fooding Group Limited Corporation Information
Table 133. Fooding Group Limited Description and Major Businesses
Table 134. Fooding Group Limited Disodium Nucleotide (I+G) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Fooding Group Limited Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Fooding Group Limited Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Disodium Nucleotide (I+G) Distributors List
Table 140. Disodium Nucleotide (I+G) Customers List
Table 141. Disodium Nucleotide (I+G) Market Trends
Table 142. Disodium Nucleotide (I+G) Market Drivers
Table 143. Disodium Nucleotide (I+G) Market Challenges
Table 144. Disodium Nucleotide (I+G) Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Disodium Nucleotide (I+G) Product Picture
Figure 2. Global Disodium Nucleotide (I+G) Market Share by Type in 2021 & 2028
Figure 3. Pharmaceutical Grade Product Picture
Figure 4. Food Grade Product Picture
Figure 5. Global Disodium Nucleotide (I+G) Market Share by Application in 2021 & 2028
Figure 6. Food
Figure 7. Pharmaceutical
Figure 8. Industry
Figure 9. Daily Chemical
Figure 10. Others
Figure 11. Disodium Nucleotide (I+G) Report Years Considered
Figure 12. Global Disodium Nucleotide (I+G) Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 13. Global Disodium Nucleotide (I+G) Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Disodium Nucleotide (I+G) Production Market Share by Region (2017-2022)
Figure 15. Global Disodium Nucleotide (I+G) Production Market Share by Region (2023-2028)
Figure 16. Disodium Nucleotide (I+G) Production Growth Rate in North America (2017-2028) & (Tons)
Figure 17. Disodium Nucleotide (I+G) Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 18. Disodium Nucleotide (I+G) Production Growth Rate in China (2017-2028) & (Tons)
Figure 19. Disodium Nucleotide (I+G) Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 20. Global Disodium Nucleotide (I+G) Sales 2017-2028 (Tons)
Figure 21. Global Disodium Nucleotide (I+G) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 22. Global Disodium Nucleotide (I+G) Revenue 2017-2028 (US$ Million)
Figure 23. Global Disodium Nucleotide (I+G) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 24. Global Disodium Nucleotide (I+G) Sales Market Share by Region (2017-2022)
Figure 25. Global Disodium Nucleotide (I+G) Sales Market Share by Region (2023-2028)
Figure 26. North America Disodium Nucleotide (I+G) Sales YoY (2017-2028) & (Tons)
Figure 27. North America Disodium Nucleotide (I+G) Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Europe Disodium Nucleotide (I+G) Sales YoY (2017-2028) & (Tons)
Figure 29. Europe Disodium Nucleotide (I+G) Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Disodium Nucleotide (I+G) Sales YoY (2017-2028) & (Tons)
Figure 31. Asia-Pacific Disodium Nucleotide (I+G) Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Latin America Disodium Nucleotide (I+G) Sales YoY (2017-2028) & (Tons)
Figure 33. Latin America Disodium Nucleotide (I+G) Revenue YoY (2017-2028) & (US$ Million)
Figure 34. Middle East & Africa Disodium Nucleotide (I+G) Sales YoY (2017-2028) & (Tons)
Figure 35. Middle East & Africa Disodium Nucleotide (I+G) Revenue YoY (2017-2028) & (US$ Million)
Figure 36. The Disodium Nucleotide (I+G) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 37. The Top 5 and 10 Largest Manufacturers of Disodium Nucleotide (I+G) in the World: Market Share by Disodium Nucleotide (I+G) Revenue in 2021
Figure 38. Disodium Nucleotide (I+G) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 39. Global Disodium Nucleotide (I+G) Sales Market Share by Type (2017-2028)
Figure 40. Global Disodium Nucleotide (I+G) Revenue Market Share by Type (2017-2028)
Figure 41. Global Disodium Nucleotide (I+G) Sales Market Share by Application (2017-2028)
Figure 42. Global Disodium Nucleotide (I+G) Revenue Market Share by Application (2017-2028)
Figure 43. North America Disodium Nucleotide (I+G) Sales Market Share by Type (2017-2028)
Figure 44. North America Disodium Nucleotide (I+G) Revenue Market Share by Type (2017-2028)
Figure 45. North America Disodium Nucleotide (I+G) Sales Market Share by Application (2017-2028)
Figure 46. North America Disodium Nucleotide (I+G) Revenue Market Share by Application (2017-2028)
Figure 47. North America Disodium Nucleotide (I+G) Sales Share by Country (2017-2028)
Figure 48. North America Disodium Nucleotide (I+G) Revenue Share by Country (2017-2028)
Figure 49. United States Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 50. Canada Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 51. Europe Disodium Nucleotide (I+G) Sales Market Share by Type (2017-2028)
Figure 52. Europe Disodium Nucleotide (I+G) Revenue Market Share by Type (2017-2028)
Figure 53. Europe Disodium Nucleotide (I+G) Sales Market Share by Application (2017-2028)
Figure 54. Europe Disodium Nucleotide (I+G) Revenue Market Share by Application (2017-2028)
Figure 55. Europe Disodium Nucleotide (I+G) Sales Share by Country (2017-2028)
Figure 56. Europe Disodium Nucleotide (I+G) Revenue Share by Country (2017-2028)
Figure 57. Germany Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 58. France Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 59. U.K. Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 60. Italy Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 61. Russia Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 62. Asia Pacific Disodium Nucleotide (I+G) Sales Market Share by Type (2017-2028)
Figure 63. Asia Pacific Disodium Nucleotide (I+G) Revenue Market Share by Type (2017-2028)
Figure 64. Asia Pacific Disodium Nucleotide (I+G) Sales Market Share by Application (2017-2028)
Figure 65. Asia Pacific Disodium Nucleotide (I+G) Revenue Market Share by Application (2017-2028)
Figure 66. Asia Pacific Disodium Nucleotide (I+G) Sales Share by Region (2017-2028)
Figure 67. Asia Pacific Disodium Nucleotide (I+G) Revenue Share by Region (2017-2028)
Figure 68. China Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 69. Japan Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 70. South Korea Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 71. India Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 72. Australia Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 73. China Taiwan Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 74. Indonesia Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 75. Thailand Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 76. Malaysia Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 77. Latin America Disodium Nucleotide (I+G) Sales Market Share by Type (2017-2028)
Figure 78. Latin America Disodium Nucleotide (I+G) Revenue Market Share by Type (2017-2028)
Figure 79. Latin America Disodium Nucleotide (I+G) Sales Market Share by Application (2017-2028)
Figure 80. Latin America Disodium Nucleotide (I+G) Revenue Market Share by Application (2017-2028)
Figure 81. Latin America Disodium Nucleotide (I+G) Sales Share by Country (2017-2028)
Figure 82. Latin America Disodium Nucleotide (I+G) Revenue Share by Country (2017-2028)
Figure 83. Mexico Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 84. Brazil Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 85. Argentina Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 86. Colombia Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 87. Middle East and Africa Disodium Nucleotide (I+G) Sales Market Share by Type (2017-2028)
Figure 88. Middle East and Africa Disodium Nucleotide (I+G) Revenue Market Share by Type (2017-2028)
Figure 89. Middle East and Africa Disodium Nucleotide (I+G) Sales Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Disodium Nucleotide (I+G) Revenue Market Share by Application (2017-2028)
Figure 91. Middle East and Africa Disodium Nucleotide (I+G) Sales Share by Country (2017-2028)
Figure 92. Middle East and Africa Disodium Nucleotide (I+G) Revenue Share by Country (2017-2028)
Figure 93. Turkey Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 94. Saudi Arabia Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 95. UAE Disodium Nucleotide (I+G) Revenue (2017-2028) & (US$ Million)
Figure 96. Disodium Nucleotide (I+G) Value Chain
Figure 97. Disodium Nucleotide (I+G) Production Process
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed